Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
131I-F16SIP in Advanced Cancer
NCT01240720Phase 2Completed
- Sponsor
- Philogen
- Start
- Sep 2008
- Primary completion
- Nov 2011
- Modality
- Antibody Fragments
- Countries
- 1
01
Overview
A Phase 2 trial of Tenarad in solid tumor, lymphoproliferative disorders (LPD), lung cancer, prostate cancer (PCa), colorectal cancer (CRC), sponsored by Philogen. Started Sep 2008; status: completed.
02
Drugs
Tenarad
03
Conditions
solid tumorlymphoproliferative disorders (LPD)lung cancerprostate cancer (PCa)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01240720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01240720.